Stocktoria
SHOULDER INNOVATIONS, INC. SI
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-07-31
SHOULDER INNOVATIONS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $47.3M | $31.6M |
| Gross profit | $36.2M | $24.3M |
| R&D expense | $7.7M | $4.5M |
| SG&A expense | $54.8M | $34.5M |
| Operating income | -$26.3M | -$14.7M |
| Income tax | $0 | $0 |
| Net income | -$40.4M | -$15.6M |
| EPS (diluted) | $-4.65 | $-242.04 |
| Operating cash flow | -$28.6M | -$14.1M |
| Free cash flow | -$36.0M | -$18.2M |
| Cash & equivalents | $26.9M | $6.1M |
| Inventory | $21.6M | $14.0M |
| Total assets | $169.9M | $43.1M |
| Total liabilities | $29.2M | $23.3M |
| Shareholders' equity | $140.8M | -$54.7M |
Source: SEC EDGAR filings · CIK 0001699350 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.